A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection
Clinical trial NCT02604199 · TERMINATED
Trial details
- NCT number
- NCT02604199
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-01-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.